Drug Database
Back to search

France· FR:61045113

FEBUXOSTAT ALMUS 120 mg, comprimé pelliculé

A febuxostat product containing fébuxostat hémihydraté, registered in France by ALMUS FRANCE, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC M04AA03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFEBUXOSTAT ALMUS 120 mg, comprimé pel…ATCM04AA03REGISTER NO.FR:61045113PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fébuxostat hémihydratéAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Febuxostat is registered in 19 of 19 countries.

Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search febuxostat products by name

Febuxostat · ATC M04AA03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of febuxostat costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.

  • France: $0.34 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Febuxostat · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.89
  • IT Italy$0.69
  • ES Spain$0.54
  • FR France$0.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FÉBUXOSTAT HÉMIHYDRATÉ
Manufacturer
ALMUS FRANCE
Country
France (FR)
ATC code
M04AA03
ATC class
Febuxostat
Defined daily dose
80 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930133507
    plaquette(s) PVC PVDC aluminium de 28 comprimé(s)
    EUR 8.31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for febuxostat.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check febuxostat against other medicinesHow interaction checks work

Febuxostat · interactions on record

25 records

  • 6 severe
  • 19 moderate

Most severe, free to view

  • MercaptopurineL01BB02severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Febuxostat in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All febuxostat products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Bulgaria · Форур
  • Germany · Febuxostat Zentiva
  • Spain · Febuxostat Mabo
  • Hungary · Forure
  • Italy · Uriquid
  • Romania · Forure

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1d234000-e4e3-4126-90b2-35ee272e7936
GET /v1/drugs/1d234000-e4e3-4126-90b2-35ee272e7936?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61045113",
  "date_amm": "2018-02-12",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "FÉBUXOSTAT HÉMIHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about febuxostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console